Feltl & Co downgraded Dipexium Pharmaceuticals (NASDAQ: DPRX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

Dipexium Pharma (DPRX) Resumes Trading Following LUDP HaltOctober 25, 2016 12:35 PM Dipexium Pharma (DPRX) Halted LUDPOctober 25, 2016 12:28 PM Dipexium Pharma (DPRX) Announces Locilex Phase 3s Missed Primary EndpointsOctober 25, 2016 7:04 AM Dipexium Announces Top-line Data from OneStep Phase 3 Trials with Locilex® in Mild Diabetic Foot Infection Did Not Meet Primary Clinical Endpoint of Superiority Versus Vehicle Plus Standardized WoundOctober 25, 2016 7:01 AM